Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised JURA Bio on both the financing transaction and the collaboration agreement. JURA Bio announced a research collaboration with Syena, a cell...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised 4me on the transaction. 4me®, a SaaS-based IT Service Management (ITSM) and Enterprise Service Management (ESM) software vendor, has announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ThayerMahan on the transaction. ThayerMahan, a world leader in autonomous maritime surveillance solutions, announced the closing of a $30 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Arcellx on the deal. Arcellx, a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal. Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Perrone Robotics on the deal. CapStone Holdings, a business incubator and investment group, announced a $10 million equity investment in...
You must be a Standard 1 Year member to access this content.
